We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+3.9%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$7.44B
AUM Growth
+$643M
Cap. Flow
+$405M
Cap. Flow %
5.44%
Top 10 Hldgs %
21.36%
Holding
2,115
New
187
Increased
1,084
Reduced
645
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 5.25%
2 Financials 4.88%
3 Healthcare 4.37%
4 Industrials 4.06%
5 Communication Services 3.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCP
1951
DELISTED
J.C. Penney Company, Inc.
JCP
$55K ﹤0.01%
14,378
-1,018
-7% -$4.5K
IEC
1952
DELISTED
IEC Electronics Corp.
IEC
$54K ﹤0.01%
10,853
MNKD icon
1953
MannKind Corp
MNKD
$1.29B
$53K ﹤0.01%
24,393
CGEN icon
1954
Compugen
CGEN
$220M
$52K ﹤0.01%
13,575
-8,920
-40% -$31K
AMRN
1955
Amarin Corp
AMRN
$301M
$50K ﹤0.01%
711
-156
-18% -$11.1K
ARWR icon
1956
Arrowhead Research
ARWR
$12.5B
$46K ﹤0.01%
10,600
XTNT icon
1957
Xtant Medical Holdings
XTNT
$61.8M
$46K ﹤0.01%
5,357
+4,290
+402% +$38.4K
PLUG icon
1958
Plug Power
PLUG
$2.92B
$45K ﹤0.01%
17,236
+1,005
+6% +$2.24K
ACGN
1959
DELISTED
Aceragen Inc
ACGN
$40K ﹤0.01%
132
SDLP
1960
DELISTED
SEADRILL PARTNERS LLC
SDLP
$40K ﹤0.01%
1,065
WPRT
1961
Westport Fuel Systems
WPRT
$36.5M
$35K ﹤0.01%
1,074
+10
+0.9% +$225
SEAC
1962
DELISTED
Seachange International Inc
SEAC
$35K ﹤0.01%
645
-175
-21% -$9.44K
CEMP
1963
DELISTED
Cempra, Inc.
CEMP
$35K ﹤0.01%
10,800
EPE
1964
DELISTED
EP Energy Corporation
EPE
$33K ﹤0.01%
10,000
UQM
1965
DELISTED
UQM Technologies, Inc.
UQM
$30K ﹤0.01%
26,114
ATHX
1966
DELISTED
Athersys, Inc. Common Stock
ATHX
$29K ﹤0.01%
560
GPUS
1967
Hyperscale Data Inc
GPUS
$55.1M
0
NVIV
1968
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$28K ﹤0.01%
1
REFR icon
1969
Research Frontiers
REFR
$17.4M
$26K ﹤0.01%
21,800
+4,100
+23% +$4.92K
EXK
1970
Endeavour Silver
EXK
$2.98B
$24K ﹤0.01%
10,010
-100
-1% -$257
HOV icon
1971
Hovnanian Enterprises
HOV
$772M
$23K ﹤0.01%
474
-100
-17% -$5.35K
CRNT icon
1972
Ceragon Networks
CRNT
$195M
$22K ﹤0.01%
10,735
TURN
1973
DELISTED
180 Degree Capital
TURN
$22K ﹤0.01%
4,308
ASXC
1974
DELISTED
Asensus Surgical, Inc.
ASXC
$21K ﹤0.01%
1,135
PLM
1975
DELISTED
PolyMet Mining Corp.
PLM
$20K ﹤0.01%
3,359

Similar funds

Cambridge Investment Research Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Cambridge Investment Research Advisors held 2,115 positions worth $7.44B, up 9.5% from $6.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $405M of net new capital in Q3 2017, opening 187 new positions and adding to 1,084 existing holdings. Its largest new stake was State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF: 203,616 shares worth $7.25M.

By sector, the portfolio is most concentrated in Technology at 5.2% of assets, up from 5% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was First Trust Large Cap Value AlphaDEX Fund, an estimated $16.3M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2017 buy was State Street SPDR MSCI EAFE Fossil Fuel Reserves Free ETF: 203,616 shares worth $7.25M.
  • Cambridge Investment Research Advisors added most to Vanguard FTSE Europe ETF in Q3 2017, an estimated $21.5M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2017 reduction was First Trust Large Cap Value AlphaDEX Fund, cutting an estimated $16.3M.
  • Cambridge Investment Research Advisors fully exited State Street SPDR Bloomberg Investment Grade Floating Rate ETF in Q3 2017, selling an estimated $8.09M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $7.44B portfolio in Q3 2017.
  • Cambridge Investment Research Advisors opened 187 new positions and closed 119 in Q3 2017.
  • Cambridge Investment Research Advisors's portfolio value rose 9.5% quarter-over-quarter to $7.44B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2017, filed 7 Nov 2017.